14-day Premium Trial Subscription Sign Up For FreeGet Free

When Should You SELL Your Stocks? Click to watch.

Coherus BioSciences Stock Forecast

NASDAQ:CHRS BUY SELL

$8.31 (5.06%)

Volume: 993.914k

Closed: May 20, 2022

Hollow Logo Score: -2.295

Coherus BioSciences Stock Forecast

BUY SELL NASDAQ:CHRS
$8.31 (5.06%)

Volume: 993.914k

Closed: May 20, 2022

Score Hollow Logo -2.295

Coherus BioSciences Stock Price (Quote) NASDAQ:CHRS

$8.31 ( 5.06% ) Friday, 20th May 2022

Range Low Price High Price Comment
30 days $7.24 $10.56 Friday, 20th May 2022 CHRS stock ended at $8.31. This is 5.06% more than the trading day before Thursday, 19th May 2022. During the day the stock fluctuated 7.87% from a day low at $7.75 to a day high of $8.36.
90 days $7.24 $13.46
52 weeks $7.24 $19.32

Historical Coherus BioSciences prices

Date Open High Low Close Volume
2022-05-20 $7.97 $8.36 $7.75 $8.31 993 914
2022-05-19 $7.47 $7.94 $7.34 $7.91 1 533 044
2022-05-18 $7.62 $7.70 $7.24 $7.45 1 392 138
2022-05-17 $7.70 $7.95 $7.61 $7.91 1 037 288
2022-05-16 $7.87 $8.10 $7.57 $7.60 1 316 987
2022-05-13 $7.93 $8.02 $7.54 $7.95 1 498 405
2022-05-12 $7.61 $7.88 $7.41 $7.59 1 616 192
2022-05-11 $8.41 $8.58 $7.73 $7.75 1 387 882
2022-05-10 $8.34 $8.76 $8.26 $8.52 1 325 588
2022-05-09 $8.10 $8.60 $7.98 $8.03 1 522 784
2022-05-06 $8.63 $9.18 $8.41 $8.43 1 128 666
2022-05-05 $9.68 $9.90 $8.73 $8.82 1 221 872
2022-05-04 $9.68 $9.75 $8.98 $9.72 1 034 660
2022-05-03 $9.66 $9.87 $9.35 $9.71 962 827
2022-05-02 $8.91 $9.68 $8.65 $9.68 1 689 249
2022-04-29 $9.30 $9.56 $9.01 $9.04 582 671
2022-04-28 $9.39 $9.56 $9.02 $9.43 850 554
2022-04-27 $9.35 $9.60 $9.22 $9.28 575 719
2022-04-26 $9.52 $9.61 $9.31 $9.36 840 063
2022-04-25 $9.49 $9.76 $9.34 $9.62 855 111
2022-04-22 $9.82 $9.94 $9.57 $9.61 715 500
2022-04-21 $10.16 $10.39 $9.81 $9.86 1 025 500
2022-04-20 $10.56 $10.56 $9.91 $10.10 1 175 300
2022-04-19 $10.47 $10.75 $10.26 $10.38 752 300
2022-04-18 $11.21 $11.34 $10.47 $10.51 930 300
2022-04-14 $11.60 $11.65 $11.20 $11.25 603 490
2022-04-13 $11.70 $12.10 $11.56 $11.62 739 453
2022-04-12 $12.24 $12.56 $11.52 $11.81 936 425
2022-04-11 $12.41 $12.74 $12.08 $12.16 702 559
2022-04-08 $12.51 $12.93 $12.46 $12.50 472 100
2022-04-07 $12.67 $12.89 $12.51 $12.56 369 200
2022-04-06 $12.48 $12.96 $12.48 $12.75 514 400
2022-04-05 $13.25 $13.36 $12.40 $12.59 945 700
2022-04-04 $12.90 $13.39 $12.85 $13.23 511 400
2022-04-01 $12.94 $13.07 $12.48 $12.85 746 104
2022-03-31 $12.84 $13.29 $12.84 $12.91 330 566
2022-03-30 $12.69 $13.46 $12.50 $12.84 736 010
2022-03-29 $12.35 $12.99 $12.05 $12.76 1 193 800
2022-03-28 $12.48 $12.57 $11.72 $11.97 832 800
2022-03-25 $12.82 $12.82 $12.38 $12.43 453 100
2022-03-24 $12.57 $12.92 $12.44 $12.89 476 300
2022-03-23 $12.48 $12.94 $12.45 $12.51 816 100
2022-03-22 $12.19 $12.54 $12.06 $12.43 818 829
2022-03-21 $13.22 $13.31 $12.11 $12.16 817 470
2022-03-18 $12.86 $13.34 $12.75 $13.31 2 044 668
2022-03-17 $12.82 $13.02 $12.57 $12.84 667 800
2022-03-16 $12.63 $12.95 $12.36 $12.89 835 600
2022-03-15 $12.23 $12.94 $11.98 $12.54 876 200
2022-03-14 $12.15 $12.72 $11.96 $12.06 794 800
2022-03-11 $12.58 $12.82 $12.27 $12.33 584 000

About Coherus BioSciences

Coherus BioSciences Coherus Biosciences, Inc., a late-stage clinical biologics platform company, focuses on developing and commercializing biosimilar products worldwide. The company’s product candidates include CHS-1701, a pegfilgrastim biosimilar candidate, which has completed a Phase I study for the prevention of chemotherapy-induced neutropenia; CHS-0214, an etanercept biosimilar candidate, which is in Phase III clinical trials for the treatment of rheumatoid ar... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!
.

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT